Medical student overshadowed by pharmaceutical influence

Doctor-Patient Relationships: Are Medical Students Too Cozy with Pharma?

Reese Marlowe in Health & Wellness June 2025 • 4 min read.

"New study reveals the concerning trends of pharmaceutical industry influence on future doctors. Learn how these interactions can impact patient care and what's being done to address it."

The relationship between doctors and pharmaceutical companies has always been a delicate balance. On one hand, pharmaceutical companies play a crucial role in developing life-saving medications and treatments. On the other hand, their primary goal is to sell those products, which can sometimes lead to conflicts of interest. But what happens when these interactions begin even earlier, during medical school? A new study sheds light on the interactions between Japanese medical students and the pharmaceutical industry, raising concerns about potential influences on future medical practice.

Studies across the globe have highlighted that the pharmaceutical industry frequently engages not only with practicing physicians but also with medical students. This early exposure is particularly concerning because trainees and students are more vulnerable to the influence of these interactions. There are fears this may lead to compromised prescribing habits further down the line, where students may be more likely to prescribe medication from companies that have engaged and courted them.

Recognizing these risks, regulatory bodies and medical organizations have attempted to set boundaries. For example, in 2013, the Japan Pharmaceutical Manufacturers Association revised its promotion code to specify limits on promotional aids. But have these measures been effective? A follow-up survey aimed to investigate whether Japanese medical students' interactions with the pharmaceutical industry changed between 2012 and 2016. The results might surprise you.

Inside the Study: What Did Researchers Find?

Medical student overshadowed by pharmaceutical influence

Researchers solicited participation from medical schools across Japan, administering anonymous surveys to medical students between May 2016 and March 2017. The survey explored the nature and frequency of their interactions with pharmaceutical companies. The data was then compared to a previous study conducted in 2012 to identify any shifts in these relationships.

Forty of the 80 medical schools in Japan participated, yielding a substantial response rate of 74.1%. This included 6,771 evaluable responses from both preclinical and clinical students. The findings revealed a few key trends:

High Acceptance Rates: Over 98% of clinical students reported having accepted stationery, brochures, or lunch from pharmaceutical companies.
Increased Interactions: A significantly higher percentage of clinical students accepted these items in 2016 compared to 2012.
Textbook Boost: Ten percent more students had received a textbook from pharmaceutical companies in 2016 than in 2012.

These results indicate that interactions between clinical students and pharmaceutical companies actually increased slightly between 2012 and 2016, despite efforts to regulate such engagements. This raises some serious questions about the effectiveness of current guidelines and the potential long-term impact on prescribing practices.

Why Does This Matter?

The increasing interactions between medical students and pharmaceutical companies can have lasting consequences on patient care and the integrity of the medical profession. As future doctors, medical students should be trained to make unbiased decisions based on scientific evidence and patient needs, not influenced by marketing tactics or promotional offers. It is essential to promote open discussions and implement stricter regulations to ensure that medical education remains free from undue influence.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1371/journal.pone.0206543, Alternate LINK

Title: Follow-Up Survey Of Japanese Medical Students’ Interactions With The Pharmaceutical Industry

Subject: Multidisciplinary

Journal: PLOS ONE

Publisher: Public Library of Science (PLoS)

Authors: Sayaka Saito, Takami Maeno, Yasushi Miyata, Tetsuhiro Maeno

Published: 2018-11-02

Everything You Need To Know

What did the study discover about the interactions between medical students and pharmaceutical companies?

The study highlights the increasing interactions between Japanese medical students and pharmaceutical companies. Specifically, over 98% of clinical students reported accepting promotional items like stationery, brochures, or lunch. Also, the number of students receiving textbooks from pharmaceutical companies increased between 2012 and 2016. This indicates a continued, and in some cases, growing influence of the pharmaceutical industry on future doctors.

Why are the interactions between medical students and pharmaceutical companies a concern?

The interactions between medical students and pharmaceutical companies are significant because they may lead to future doctors making prescribing decisions influenced by marketing efforts rather than unbiased medical evidence. The findings show that the interactions between clinical students and pharmaceutical companies increased slightly between 2012 and 2016 despite efforts to regulate the engagements. This could impact the quality of patient care and the integrity of the medical profession as medical students may be more likely to prescribe medication from companies that have engaged and courted them.

Why are medical students considered particularly vulnerable to the influence of pharmaceutical companies?

Medical students are particularly vulnerable to the influence of pharmaceutical companies because they are in a learning and formative stage of their careers. Their prescribing habits are being developed, and they may not have the experience or the critical thinking skills to fully evaluate information presented to them by pharmaceutical companies. This early exposure raises concerns about the objectivity of their future prescribing practices.

What are the implications of medical students interacting with pharmaceutical companies?

The study reveals that medical students are interacting with the pharmaceutical industry, even accepting gifts, lunches, and textbooks. These interactions could lead to conflicts of interest, where medical students, as future doctors, might be inclined to prescribe medications from the companies that provided them with these items. This raises questions about the objectivity of their prescribing practices. Furthermore, these interactions can impact the training of medical students who should make unbiased decisions based on scientific evidence and patient needs, not influenced by marketing tactics or promotional offers.

What measures have been taken to regulate interactions between medical students and pharmaceutical companies, and have they been effective?

Regulatory bodies and medical organizations have attempted to address the influence of pharmaceutical companies on medical students by setting boundaries and revising promotion codes, like the Japan Pharmaceutical Manufacturers Association's revision of its promotion code in 2013. However, the study suggests that these measures may not be completely effective, as interactions between clinical students and pharmaceutical companies increased between 2012 and 2016. Further discussions and stricter regulations are needed to ensure that medical education remains free from undue influence and that patient care is prioritized.